| Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation |
|
|
|
|
|
|
|
|
|
| Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery |
|
|
|
|
|
|
|
|
|
| The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer |
|
|
|
|
|
|
|
|
|
| Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients |
|
|
|
|
|
|
|
|
|
| SNP association study in PMS2-associated Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma |
|
|
|
|
|
|
|
|
|
| Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort |
|
|
|
|
|
|
|
|
|
| Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis |
|
|
|
|
|
|
|
|
|
| Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population |
|
|
|
|
|
|
|
|
|
| Genotype phenotype correlation in Asian Indian von Hippel–Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma |
|
|
|
|
|
|
✓ |
|
Asian Indian |
| Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer |
|
|
|
|
|
|
|
|
|
| Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer |
|
|
|
|
|
|
|
|
|
| Development of a high risk pancreatic screening clinic using 3.0 T MRI |
|
|
|
|
|
|
|
|
|
| Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics |
|
|
|
|
|
|
|
|
|
| Corrections to: Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries |
|
|
|
|
|
|
|
|
|
| Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge |
|
|
|
|
|
|
|
|
|
| Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine |
|
|
|
|
|
|
|
|
|
| Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations |
|
|
|
|
|
|
|
|
|
| Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy |
|
|
|
|
|
|
|
|
|
| Penetrance of a rare familial mutation predisposing to papillary thyroid cancer |
|
|
|
|
|
|
|
|
|
| Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) cli |
|
|
|
|
|
|
|
|
|
| Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer |
|
|
|
|
|
|
|
|
|
| Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing |
|
|
|
|
|
|
|
|
|
| Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers |
|
|
|
|
|
|
|
|
|
| Mutations in context: implications of BRCA testing in diverse populations |
|
|
|
|
|
|
|
|
|
| Germline mutations in lung cancer and personalized medicine |
|
|
|
|
|
|
|
|
|
| International society for gastrointestinal hereditary tumours—InSiGHT |
|
|
|
|
|
|
|
|
|
| An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review |
|
|
|
|
|
|
|
|
|
| Dental anomalies in pediatric patients with familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature |
|
|
|
|
|
|
|
|
|
| Discovery of mutations in homologous recombination genes in African-American women with breast cancer |
|
|
|
|
|
|
✓ |
|
African-American women |
| Cancer patients’ intentions towards receiving unsolicited genetic information obtained using next-generation sequencing |
|
|
|
|
|
|
|
|
|
| Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations |
|
|
|
|
|
|
|
|
|
| Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations |
|
|
|
|
|
|
|
|
|
| Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan |
|
|
|
|
|
|
|
|
|
| A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay |
|
|
|
|
|
|
|
|
|
| p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers |
|
|
|
|
|
|
|
|
|
| Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation |
|
|
|
|
|
|
|
|
|
| Erratum to: A new hereditary colorectal cancer network in the Middle East and eastern Mediterranean countries to improve care for high-risk families |
|
|
|
|
|
|
|
|
|
| Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literatur |
|
|
|
|
|
|
|
|
|
| The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes |
|
|
|
|
|
|
|
|
|
| A comparison of cosegregation analysis methods for the clinical setting |
|
|
|
|
|
|
|
|
|
| Association of genetic variations in RTN4 3′-UTR with risk for clear cell renal cell carcinoma |
|
|
|
|
|
|
|
|
|
| A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families |
|
|
|
|
|
|
|
|
|
| Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin |
|
|
|
|
|
|
✓ |
|
Slavic origin |
| Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations |
|
|
|
|
|
|
|
|
|
| Issues related to family history of cancer at the end of life: a palliative care providers’ survey |
|
|
|
|
|
|
|
|
|
| Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland |
|
|
|
|
|
|
|
|
|
| Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing |
|
|
|
|
|
|
|
|
|
| The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations |
|
|
|
|
|
|
|
|
|
| Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas |
|
|
|
|
|
|
|
|
|
| Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion |
|
|
|
|
|
|
|
|
|
| Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries |
|
|
|
|
|
|
|
|
|
| A single visit multidisciplinary model for managing patients with mutations in moderate and high-risk genes in a community practice setting |
|
|
|
|
|
|
|
|
|
| Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing |
|
|
|
|
|
|
|
|
|
| Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel |
|
|
|
|
|
|
|
|
|
| Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families |
|
|
|
|
|
|
|
|
|
| Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers |
|
|
|
|
|
|
|
|
|
| RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers |
|
|
|
|
|
|
|
|
|
| A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families |
|
|
|
|
|
|
|
|
|
| Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes |
|
|
|
|
|
|
|
|
|
| A multi-gene panel study in hereditary breast and ovarian cancer in Colombia |
|
|
|
|
|
|
|
|
|
| Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6 |
|
|
|
|
|
|
|
|
|
| Next generation sequencing is informing phenotype: a TP53 example |
|
|
|
|
|
|
|
|
|
| The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Heightened perception of breast cancer risk in young women at risk of familial breast cancer |
|
|
|
|
|
|
|
|
|
| Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation? |
|
|
|
|
|
|
|
|
|
| TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma |
|
|
|
|
|
|
|
|
|
| Gestational choriocarcinoma associated with a germline TP53 mutation |
|
|
|
|
|
|
|
|
|
| Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features i |
|
|
|
|
|
|
|
|
|
| Placing negative multi-gene panel results into clinical context |
|
|
|
|
|
|
|
|
|
| General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey |
|
|
|
|
|
|
|
|
|
| Importance of updating family cancer history in childhood cancer survivors |
|
|
|
|
|
|
|
|
|
| Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerations |
|
|
|
|
|
|
|
|
|
| How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study |
|
|
|
|
|
|
|
|
|
| A Peutz–Jeghers syndrome family associated with sinonasal adenocarcinoma: 28 years follow up report |
|
|
|
|
|
|
|
|
|
| A new POT1 germline mutation—expanding the spectrum of POT1-associated cancers |
|
|
|
|
|
|
|
|
|
| Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer |
|
|
|
|
|
|
|
|
|
| Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population |
|
|
|
|
|
|
|
|
|
| Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria |
|
|
|
|
|
|
|
|
|
| A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA |
|
|
|
|
|
|
|
|
|
| All in the family? Communication of cancer survivors with their families |
|
|
|
|
|
|
|
|
|
| Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers |
|
|
|
|
|
|
|
|
|
| Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics |
|
|
|
|
|
|
|
|
|
| Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer |
|
|
|
|
|
|
|
|
|
| Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine |
|
|
|
|
|
|
|
|
|
| Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series |
|
|
|
|
|
|
|
|
|
| Gastric tumours in FAP |
|
|
|
|
|
|
|
|
|
| Patients with negative multi-gene panel testing: a back to the future paradox? |
|
|
|
|
|
|
|
|
|
| High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations |
|
|
|
|
|
|
|
|
|
| Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia |
|
|
|
|
|
|
✓ |
|
black South African |
| A lesson from a reported pathogenic variant in Peutz-Jeghers syndrome: a case report |
|
|
|
|
|
|
|
|
|
| Gastric cancer in FAP: a concerning rise in incidence |
|
|
|
|
|
|
|
|
|
| Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens |
|
|
|
|
|
|
|
|
|
| Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives |
|
|
|
|
|
|
|
|
|
| The association between prognosis of breast cancer and first-degree family history of breast or ovarian cancer: a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? |
|
|
|
|
|
|
|
|
|
| Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer |
|
|
|
|
|
|
|
|
|
| Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls |
|
|
|
|
|
|
|
|
|
| Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study |
|
|
|
|
|
|
|
|
|